Katalin Monostory
Chemical Research Center
Hungarian Academy of Sciences
Budapest
Hungary
Name/email consistency: high
- Steroid regulation of drug-metabolizing cytochromes P450. Monostory, K., Dvorak, Z. Curr. Drug Metab. (2011)
- Hormonal regulation of CYP1A expression. Monostory, K., Pascussi, J.M., Kóbori, L., Dvorak, Z. Drug Metab. Rev. (2009)
- Drug interaction potential of 2-((3,4-dichlorophenethyl)(propyl)amino)-1-(pyridin-3-yl)ethanol (LK-935), the novel nonstatin-type cholesterol-lowering agent. Monostory, K., Pascussi, J.M., Szabó, P., Temesvári, M., Köhalmy, K., Acimovic, J., Kocjan, D., Kuzman, D., Wilzewski, B., Bernhardt, R., Kóbori, L., Rozman, D. Drug Metab. Dispos. (2009)
- The effect of synthetic glucocorticoid, dexamethasone on CYP1A1 inducibility in adult rat and human hepatocytes. Monostory, K., Kohalmy, K., Prough, R.A., Kóbori, L., Vereczkey, L. FEBS Lett. (2005)
- Role of CYP2E1 in deramciclane metabolism. Monostory, K., Köhalmy, K., Hazai, E., Vereczkey, L., Kóbori, L. Drug Metab. Dispos. (2005)
- Biotransformation of deramciclane in primary hepatocytes of rat, mouse, rabbit, dog, and human. Monostory, K., Kohalmy, K., Ludányi, K., Czira, G., Holly, S., Vereczkey, L., Urmös, I., Klebovich, I., Kóbori, L. Drug Metab. Dispos. (2005)
- Inhibition of cytochrome P450 enzymes participating in p-nitrophenol hydroxylation by drugs known as CYP2E1 inhibitors. Monostory, K., Hazai, E., Vereczkey, L. Chem. Biol. Interact. (2004)
- GYKI-47261, a new AMPA [2-amino-3-(3-hydroxymethylisoxazole-4-yl)propionic acid] antagonist, is a CYP2E1 inducer. Tamási, V., Hazai, E., Porsmyr-Palmertz, M., Ingelman-Sundberg, M., Vereczkey, L., Monostory, K. Drug Metab. Dispos. (2003)









